ABCG13 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Role of ABCG13

ABCG13 is a half-size ABC transporter involved in the secretion of cuticular lipids, particularly in flower petals and carpels. Key findings include:

  • Function in Cuticle Formation: ABCG13 facilitates the transport of flower-specific cutin monomers and wax precursors to the extracellular matrix, forming a hydrophobic barrier that prevents water loss and pathogen invasion .

  • Genetic Knockout Effects: abcg13 mutants exhibit post-genital organ fusions, reduced flower cutin content, and abnormal petal epidermal cell structure .

  • Tissue-Specific Expression: ABCG13 is predominantly expressed in floral tissues, with minimal activity in vegetative organs, highlighting its specialized role in reproductive biology .

ABCG13 Antibody Applications

The ABCG13 antibody is primarily used for:

  • Immunolocalization: Detecting ABCG13 protein in plant tissues via techniques like immunogold transmission electron microscopy (TEM) .

  • Phenotypic Validation: Confirming ABCG13 loss-of-function in mutants through Western blotting or flow cytometry .

Table 1: Key Experimental Findings Using ABCG13 Antibodies

Experimental ApproachKey ObservationsCitation
abcg13 knockout mutants30% reduction in flower cutin monomers; petal epidermis deformation
RNAi/artificial microRNAPost-genital fusions in flowers; disrupted cuticle integrity
Immunogold TEMLocalization of ABCG13 to plasma membrane in epidermal cells

Technical Challenges and Solutions

  • Antibody Specificity: Polyclonal antibodies raised against ABCG13 must be rigorously validated to avoid cross-reactivity with other ABCG family members (e.g., ABCG11 or ABCG12) .

  • Expression Variability: ABCG13 expression levels correlate with developmental stages, requiring careful synchronization of plant samples for consistent results .

Comparative Analysis with Other ABCG Transporters

FeatureABCG13ABCG11/ABCG12
Primary RoleFlower cuticle lipid transportStem/leaf cuticle lipid transport
Mutant PhenotypeFloral organ fusionsSeedling lethality
Tissue SpecificityFlowersEpidermis, stems
Key SubstratesFlower-specific cutin monomersStem/leaf cutin and waxes
Data synthesized from .

Future Research Directions

  • Mechanistic Studies: Elucidate how ABCG13 interacts with lipid substrates at the molecular level.

  • Agricultural Applications: Engineer ABCG13 variants to enhance drought resistance in crops via cuticle modification.

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (made-to-order)
Synonyms
ABCG13; WBC13; At1g51460; F5D21.8; ABC transporter G family member 13; ABC transporter ABCG.13; AtABCG13; White-brown complex homolog protein 13; AtWBC13
Target Names
ABCG13
Uniprot No.

Target Background

Gene References Into Functions
ABCG13 is essential for the transport of flower cuticular lipids (PMID: 21232060). [ABCG13] https://www.ncbi.nlm.nih.gov/pubmed/21232060
Database Links

KEGG: ath:AT1G51460

STRING: 3702.AT1G51460.1

UniGene: At.37812

Protein Families
ABC transporter superfamily, ABCG family, Eye pigment precursor importer (TC 3.A.1.204) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

Given the lack of specific information on "ABCG13 Antibody" in the search results, I will create a general FAQ for researchers focusing on antibody-related research, which can be adapted to any specific antibody, including hypothetical or less documented ones like "ABCG13 Antibody." This FAQ will cover aspects of experimental design, data analysis, and methodological considerations relevant to antibody research.

A:

To study the specificity of an antibody, you should:

  • Use Positive and Negative Controls: Include samples known to express and not express the target protein to validate the antibody's specificity.

  • Optimize Antibody Concentration: Determine the optimal concentration of the antibody to minimize non-specific binding.

  • Compare with Other Antibodies: Use multiple antibodies targeting the same protein to confirm results and assess specificity.

A:

Antibody validation is crucial for reliable results. Common methods include:

  • Western Blotting: To check for specific protein bands.

  • Immunofluorescence: To visualize protein localization.

  • ELISA: For quantitative assessment of antibody binding.

  • Knockdown/Knockout Experiments: To confirm specificity by reducing or eliminating the target protein.

A:

When encountering contradictory data:

  • Review Experimental Conditions: Ensure consistency in experimental setup, including antibody concentration, incubation times, and buffers.

  • Check Antibody Lot Variability: Different lots of the same antibody can have varying performance.

  • Use Multiple Detection Methods: Validate findings with different techniques (e.g., Western blot, IF, ELISA).

A:

To study the role of an antibody in a biological pathway:

  • Use Inhibitors/Activators: Manipulate the pathway with known inhibitors or activators to observe changes.

  • Cell Signaling Assays: Measure downstream signaling events affected by the antibody.

  • Cellular Assays: Perform functional assays (e.g., proliferation, apoptosis) to assess the impact of antibody treatment.

A:

To map the epitope recognized by an antibody:

  • Use Peptide Arrays: Test binding to overlapping peptides covering the protein sequence.

  • Mutagenesis Studies: Create point mutations in the protein to identify critical residues for binding.

  • Structural Studies: Use X-ray crystallography or NMR to visualize the antibody-antigen complex.

A:

To enhance generalizability:

  • Use Diverse Cell Lines or Tissues: Test the antibody in multiple cell types or tissue samples.

  • Validate Across Different Species: If applicable, confirm findings in different species to ensure cross-species relevance.

  • Consider Clinical Samples: Validate results in clinical samples if studying human diseases.

A:

Common limitations include:

  • Antibody Quality and Specificity: Addressed through rigorous validation and using high-quality antibodies.

  • Experimental Variability: Minimized by standardizing protocols and using controls.

  • Future Directions: Investigate new applications (e.g., therapeutic uses) and improve antibody engineering techniques for enhanced specificity and affinity.

Example Data Table: Antibody Validation Methods

MethodPurposeAdvantagesLimitations
Western BlotDetect specific protein bandsQuantitative, easy to performRequires protein extraction, can be non-specific
ImmunofluorescenceVisualize protein localizationProvides spatial informationRequires fixation, can be affected by fixation quality
ELISAQuantitative assessment of antibody bindingHigh throughput, sensitiveCan be affected by non-specific binding
Knockdown/KnockoutConfirm specificity by reducing/eliminating target proteinHighly specific, functional validationRequires genetic manipulation tools

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.